Population Aging and Potential Growth in Asia

We study the effects of projected population aging on potential growth in Asian economies over the period 2015–2050. We find that an increase in the share of the population over 64 years of age will significantly lower output growth through decreased labor participation. Population aging can also reduce economic growth through increased labor income taxes and dampened productivity growth

Population Aging, Government Policy and the Postwar Japanese Economy

This paper analyzes the Postwar Japanese economy with a parsimonious neoclassical growth model that incorporates the demographic transition in Japan. We find that i) productivity growth is the most important driver of the postwar economic growth, ii) the workweek reduction policy of the 1990s significantly reduced Japanese output. iii) the increase in the fraction of the population aged above 65 years old significantly reduced output relative to its potential through the decline in the employment rate and the increase in payroll tax

Contactless measurement of electrical conductivity for bulk nanostructured silver prepared by high-pressure torsion: A study of the dissipation process of giant strain

We measured the electrical conductivity of bulk nanostructured silver prepared by high-pressure torsion (HPT) in a contactless manner by observing the AC magnetic susceptibility resulting from the eddy current, so that we could quantitatively analyze the dissipation process of the residual strain with sufficient time resolution as a function of temperature T and initial shear strain γ. The HPT process was performed at room temperature under a pressure of 6 GPa for revolutions N = 0–5, and we targeted a wide range of residual shear strains. The contactless measurement without electrode preparation enabled us to investigate both the fast and slow dissipation processes of the residual strain with sufficient time resolution, so that a systematic study of these processes became possible. The changes in the electrical conductivity as a function of N at room temperature were indeed consistent with changes in the Vickers microhardness; furthermore, they were also related to changes in structural parameters such as the preferred orientation, the interplanar distance, and the crystallite size. The dissipation process at N = 1, corresponding to γ ≈ 30, was the largest and the fastest. For N = 5, corresponding to γ ≈ 140, we considered the effects of grain boundaries, as well as those of dislocations. The strain dissipation was quite slow below T = 290 K. According to the analytical results, it became successful to conduct the quantitative evaluation of the strain dissipation at arbitrary temperatures: For instance, the relaxation times at T = 280 and 260 K were estimated to be 3.6 and 37 days, respectively

High-pressure dc magnetic measurements on a bisdiselenazolyl radical ferromagnet using a vibrating-coil SQUID magnetometer

The high-pressure magnetic properties of the iodo-substituted bisdiselenazolyl radical ferromagnet IBPSSEt have been studied by vibrating-coil SQUID magnetometry. The magnetic state at a pressure (P) of approximately 2 GPa has the highest Curie temperature (TC) of 27.5 K, and displays an ideal three-dimensional (3D) ferromagnetic interaction network. The value of TC observed by ac magnetic susceptibility measurements is consistent with that obtained from dc measurements below approximately 4 GPa. Field-cooled dc measurements at more elevated pressures reveal a slow evolution of magnetic ordering, so that atP >6 GPa the structure may be described in terms of a 1D ferromagnetic chain with predominantly antiferromagnetic lateral (interchain) interactions, in accord with the results of density functional theory calculations

Establishment of a Drug Sensitivity Panel Using Human Lung Cancer Cell Lines

We established a drug sensitivity panel consisting of 24 human lung cancer cell lines. Using this panel, we evaluated 26 anti-cancer agents: three alkylators, three platinum compounds, four antimetabolites, one topoisomerase I inhibitor, five topoisomerase II inhibitors, seven antimitotic agents and three tyrosine kinase inhibitors. This panel showed the following: a) Drug sensitivity patterns reflected their clinically-established patterns of action. For example, doxorubicin and etoposide were shown to be active against small cell lung cancer cell lines and mitomycin-C and 5-fluorouracil were active against non-small cell lung cancer cell lines, in agreement with clinical data. b) Correlation analysis of the mean graphs derived from the logarithm of IC50 values of the drugs gave insight into the mechanism of each drug's action. Thus, two drug combinations with reverse or no correlation, such as the combination of cisplatin and vinorelbine, might be good candidates for the ideal two drug combination in the treatment of lung cancer, as is being confirmed in clinical trials. c) Using cluster analysis of the cell lines in the panel with their drug sensitivity patterns, we could classify the cell lines into four groups depending on the drug sensitivity similarity. This classification will be useful to elucidate the cellular mechanism of action and drug resistance. Thus, our drug sensitivity panel will be helpful to explore new drugs or to develop a new combination of anti-cancer agents for the treatment of lung cancer.</p

Growth inhibitory effects of antifolates against an adriamycin-resistant human small cell lung cancer cell line

We have established an Adriamycin (ADM) -resistant small cell lung cancer (SCLC) cell line, SBC-3/ADM100, which shows multifactorial mechanisms of resistance to ADM, such as overexpression of P-glycoprotein, an enhanced detoxifying system and a decrease in topoisomerase II activity. In the present study, we confirmed that SBC-3/ADM 100 showed collateral sensitivity to methotrexate and TNP-351, a new antifolate, though this cell line showed a typical multidrug resistance (MDR) pattern. We also demonstrated a faster uptake and higher accumulation (1.3-fold) of TNP-351 in the SBC-3/ADM100 cells than those in the parent SBC-3 cells. These results explain one of the mechanisms for collateral sensitivity in the resistant cells. Furthermore, this cell line was found to have no cross-resistance to edatrexate and minimal cross-resistance to trimetrexate, 254-S (cisplatin analog), 5-fluorouracil and 4-hydroperoxyifosfamide. These drugs will have clinical importance in patients with SCLC who were previously treated with an ADM-containing regimen. Thus, antifolates, especially TNP-351 and edatrexate, can be expected to eradicate residual multidrug resistant SCLC cells selected by ADM.</p

Novel prospective umbrella-type lung cancer registry study for clarifying clinical practice patterns: CS-Lung-003 study protocol

Introduction Conventional cancer registries are suitable for simple surveillance of cancer patients, including disease frequency and distribution, demographics, and prognosis; however, the collected data are inadequate to clarify comprehensively diverse clinical questions in daily practice. Methods We constructed an umbrella‐type lung cancer patient registry (CS‐Lung‐003) integrating multiple related prospective observational studies (linked studies) that reflect clinical questions about lung cancer treatment. The primary endpoint of this registry is to clarify daily clinical practice patterns in lung cancer treatment; a key inclusion criterion is pathologically diagnosed lung cancer. Under this registry, indispensable clinical items are detected in advance across all active linked studies and gathered prospectively and systematically to avoid excessive or insufficient data collection. Researchers are to input information mutually, irrespective of the relevance to each researcher's own study. Linked studies under the umbrella of the CS‐Lung‐003 registry will be updated annually with newly raised clinical questions; some linked studies will be newly created, while others will be deleted after the completion of the analysis. Enrollment began in July 2017. Discussion We successfully launched the umbrella‐type CS‐Lung‐003 registry. Under this single registry, researchers collaborate on patient registration and data provision for their own and other studies. Thus, the registry will produce results for multiple domains of study, providing answers to questions about lung cancer treatment raised by other researchers. Through such analysis of each linked study, this registry will contribute to the comprehensive elucidation of actual daily practice patterns in lung cancer treatment. Key points CS‐Lung‐003 registry directly integrates multiple linked studies created under the umbrella of this cancer registry to solve various clinical questions regarding daily practice patterns of lung cancer treatment

Liberation of Materials by Electrical Disintegration for Recycling

Liberation is very important to separate different materials from the wasted composites for recycling the components. It is necessary to develop the new crushing method to tear off the composites along the boundary of different materials. As the waste materials include many kinds of inorganic and organic components, it is difficult to liberate them by conventional crushing and grinding methods. In this study, the exfoliations along the boundary of materials, such as, concrete, silicon with silica, nail in wood and liquid crystal display have been investigated by electrical crushing (disintegration) method